The American Urological Association (AUA) today issued new clinical guidance – which directly contrasts recent recommendations issued by other major groups – about prostate cancer screening, asserting that the prostate-specific antigen (PSA) test should be offered to well-informed, men aged 40 years or older who have a life expectancy of at least 10 years.
The PSA […]

continue reading from " AUA counters mainstream recommendations with new best practice statement on PSA testing "

Researchers found that men who have undergone treatment for localized prostate cancer could benefit from drinking pomegranate juice.
Study results will be presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA

continue reading from " Pomegranate juice appears to slow the progression of post-treatment prostate cancer recurrence, "

Though proven effective, treating prostate cancer with the testosterone-lowering treatment known as androgen deprivation therapy may raise men’s risk for developing bone fractures and fatal cardiovascular disease, a new study suggests.
The likelihood of developing either side effect remains low, the researchers noted. But the study shines fresh light on the question of how best to […]

continue reading from " Heart, bone problems may follow prostate cancer treatment "

Differing biological response to infection between men and women may explain higher death rates among older men who are hospitalized with community-acquired pneumonia (CAP). The findings, published online in the Critical Care Medicine journal, may have important implications for understanding sex differences in life expectancy.
The researchers measured blood levels of inflammatory indicators, including tumor necrosis […]

continue reading from " Older men more likely than women to die after pneumonia "

Doctors reported Monday that a drug already sold for other prostate problems significantly cut the chances of prostate cancer being found in men with an increased risk of the disease.
According to study conclusion, dutasteride, sold as Avodart, lowered the chances of a prostate cancer diagnosis by 23 percent after four years of use.
Tens of thousands […]

continue reading from " Drug lowers risk of getting prostate cancer "

Tadalafil (Cialis), a popular drug for treating erectile dysfunction, also seems to reduce lower urinary tract symptoms (LUTS) in men with enlarged prostate.
The study has added further evidence that drugs like Tadalafil help with management of bladder outlet symptoms as well. “This is an exciting concept for men’s health,” American Urological Association (AUA) spokesman Anthony […]

continue reading from " Cialis can also reduce lower urinary tract infections in men "

Vitamin D is an effective treatment for prostate cancer in some patients, a UK study suggests.
A once daily dose reduced PSA level - an indicator of severity of disease - by as much as half in 20% of patients.
There has been much interest in vitamin D in prostate cancer after studies linking risk of the […]

continue reading from " Vitamin D hope in prostate cancer "

Men with denser bones may be more likely to develop prostate cancer, Johns Hopkins researchers suggest.
The findings are being presented at the American Urological Association annual meeting, or the concurrent Engineering & Urology Society annual meeting in Chicago.

continue reading from " Bone density linked to prostate cancer "

Cholesterol-lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center.
Other Duke Prostate Center research has found that inflammation in tumors is associated with recurrent prostate cancer, so these two findings, taken together, provide more impetus for considering the use […]

continue reading from " Cholesterol-lowering medication may reduce inflammation in prostate tumors "

A “nanoparticle” topical treatment for erectile dysfunction appears to work well, at least in a study involving rats.
According to the researchers, five of seven rats developed erections after their penises received a coating of a special hybrid of nanoparticles that slowly released nitric oxide (NO), which relaxes cells in the penis to help blood vessels […]

continue reading from " Topical treatment for erectile dysfunction "